JOHN M PASQUESI, a director at $ACGL, sold 28,866 shares of the company on 12-12-2025 for an estimated $2,707,902. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.2% of their shares of this class of stock. Following this trade, they now own 526,356 shares of this class of $ACGL stock.
$ACGL Insider Trading Activity
$ACGL insiders have traded $ACGL stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ACGL stock by insiders over the last 6 months:
- JOHN M PASQUESI has made 0 purchases and 3 sales selling 212,666 shares for an estimated $19,970,730.
- MAAMOUN RAJEH (PRESIDENT, ARCH CAPITAL GROUP) sold 10,000 shares for an estimated $941,464
- FRANCOIS MORIN (EVP AND CFO) sold 8,000 shares for an estimated $756,996
- BRIAN S POSNER purchased 1,000 shares for an estimated $17,338
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ACGL Hedge Fund Activity
We have seen 409 institutional investors add shares of $ACGL stock to their portfolio, and 486 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 6,612,322 shares (-77.8%) from their portfolio in Q3 2025, for an estimated $599,935,975
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,374,877 shares (+55.4%) to their portfolio in Q3 2025, for an estimated $215,472,590
- COOKE & BIELER LP added 2,323,991 shares (+inf%) to their portfolio in Q3 2025, for an estimated $210,855,703
- FIRST TRUST ADVISORS LP added 2,279,147 shares (+409.5%) to their portfolio in Q3 2025, for an estimated $206,787,007
- MANUFACTURERS LIFE INSURANCE COMPANY, THE added 1,786,302 shares (+814.5%) to their portfolio in Q3 2025, for an estimated $162,071,180
- THRIVENT FINANCIAL FOR LUTHERANS added 1,532,200 shares (+1432.5%) to their portfolio in Q3 2025, for an estimated $139,016,506
- NUVEEN, LLC removed 1,430,239 shares (-35.8%) from their portfolio in Q3 2025, for an estimated $129,765,584
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ACGL Revenue
$ACGL had revenues of $5B in Q3 2025. This is an increase of 9.32% from the same period in the prior year.
You can track ACGL financials on Quiver Quantitative's ACGL stock page.
$ACGL Analyst Ratings
Wall Street analysts have issued reports on $ACGL in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 11/25/2025
- Morgan Stanley issued a "Overweight" rating on 11/17/2025
- Wells Fargo issued a "Overweight" rating on 10/29/2025
- Goldman Sachs issued a "Sell" rating on 10/14/2025
To track analyst ratings and price targets for $ACGL, check out Quiver Quantitative's $ACGL forecast page.
$ACGL Price Targets
Multiple analysts have issued price targets for $ACGL recently. We have seen 11 analysts offer price targets for $ACGL in the last 6 months, with a median target of $108.0.
Here are some recent targets:
- Yaron Kinar from Mizuho set a target price of $95.0 on 12/16/2025
- Harry Fong from Roth Capital set a target price of $110.0 on 12/02/2025
- Rowland Mayor from RBC Capital set a target price of $108.0 on 11/25/2025
- Michael Phillips from Morgan Stanley set a target price of $110.0 on 11/17/2025
- Elyse Greenspan from Wells Fargo set a target price of $106.0 on 10/29/2025
- Jimmy Bhullar from JP Morgan set a target price of $111.0 on 10/28/2025
- Robert Cox from Goldman Sachs set a target price of $88.0 on 10/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
